NCT07475871

Brief Summary

Severe limb trauma often requires the use of a tourniquet to stop life-threatening bleeding. While tourniquets are essential for saving lives, prolonged interruption of blood flow may lead to tissue ischemia, nerve injury, and inflammatory responses that could contribute to the development of chronic pain. The TOURNI-PAIN Study is a prospective observational study designed to investigate whether the duration of tourniquet use during the treatment of severe limb injuries is associated with an increased risk of persistent pain after recovery. The study will enroll adult patients with major upper or lower limb trauma who required tourniquet application in the prehospital or hospital setting. Researchers will collect information about the duration and characteristics of tourniquet use, details of the injury, surgical treatment, and recovery. Participants will be followed for up to 6 months after injury to assess pain levels, possible neuropathic pain, functional recovery, and quality of life. The goal of this research is to better understand whether longer tourniquet exposure increases the risk of long-term pain. The findings may help improve trauma care practices by balancing the life-saving benefits of hemorrhage control with strategies that minimize long-term complications and improve recovery for patients with severe limb injuries.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

March 15, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

Same day

First QC Date

March 13, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

TourniquetChronic PainPhantom Limb PainTrauma Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Persistent Clinically Significant Pain After Limb Trauma

    Persistent pain defined as Numeric Rating Scale (NRS) ≥4 during movement or functional activity at 3 or 6 months after injury. Pain intensity will be assessed using the standardized 0-10 Numeric Rating Scale during follow-up evaluations.

    3 and 6 months after injury

Secondary Outcomes (1)

  • Neuropathic Pain

    3 and 6 months after injury

Study Arms (1)

Severe Limb Trauma With Tourniquet Exposure

This cohort includes adult patients with severe upper or lower limb trauma who required tourniquet application for hemorrhage control in the prehospital or hospital setting. The study is observational and does not involve any study-mandated intervention. Clinical care will follow institutional trauma protocols. The primary exposure of interest is cumulative tourniquet duration (minutes). Participants will be followed prospectively to evaluate the association between tourniquet exposure and the development of persistent pain, neuropathic pain, functional outcomes, and quality of life up to 6 months after injury.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will include adult patients (≥18 years) with severe upper or lower limb trauma who required tourniquet application for hemorrhage control in the prehospital or hospital setting. Participants will be recruited from trauma centers treating combat-related and civilian traumatic injuries. Eligible patients must have documented tourniquet use and available information on tourniquet duration. The cohort will include patients undergoing limb salvage as well as those requiring primary or secondary amputation. Participants will be followed prospectively to assess the relationship between tourniquet exposure and the development of persistent pain and functional outcomes.

You may qualify if:

  • Age ≥18 years
  • Severe upper or lower limb trauma
  • Documented tourniquet use (prehospital or in-hospital)
  • Available documentation of tourniquet duration
  • Informed consent

You may not qualify if:

  • Pre-existing chronic limb pain
  • Known severe peripheral neuropathy
  • Cognitive inability to complete follow-up
  • Expected survival \<48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Superhumans War Trauma Center

Lviv, Ukraine

Location

Related Publications (1)

  • Kragh JF Jr, Walters TJ, Baer DG, Fox CJ, Wade CE, Salinas J, Holcomb JB. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma. 2008 Feb;64(2 Suppl):S38-49; discussion S49-50. doi: 10.1097/TA.0b013e31816086b1.

MeSH Terms

Conditions

PainChronic PainPhantom Limb

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic Processes

Central Study Contacts

Dmytro Dmitriy Dmytriiev, PhD.Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of science department, PhD, Professor

Study Record Dates

First Submitted

March 13, 2026

First Posted

March 17, 2026

Study Start

March 15, 2026

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared due to ethical, legal, and security considerations related to sensitive clinical data from trauma patients, including those with combat-related injuries. Data may contain potentially identifiable health information and details associated with military trauma. De-identified aggregated data may be shared upon reasonable request and subject to approval by the study investigators and institutional ethics committees, in accordance with institutional policies and applicable data protection regulations.

Locations